🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ASPERA study is enrolling patients with ischemic #stroke on anticoagulants in 48 centers from 15 countries 🌍 want to join? Don’t hesitate to ask [email protected] [email protected] [email protected] Simona Sacco Matteo Foschi Raffaele Ornello

One recurring question I often get during lectures on migraine, stroke, and PFO is about the use of antithrombotic therapy. To address this, we conducted a systematic review. Curious about the findings? Read the full article below.

Pleased to see our paper published in. Headache Journal Matteo Foschi Federico De Santis Raffaele Ornello Simona Sacco

Under the strong leadership of ESO President Simona Sacco, today’s discussions were dynamic and forward-thinking. Engaged debates, insightful exchanges, and strategic brainstorming shaped the future of #strokescience and the ESO Society. Exciting times ahead—stay tuned!

🚨 Calling stroke & cardiology centres!!! We’re launching the CLOT International Collaboration — a multicentre international study on outcomes after IV thrombolysis and mechanical Thrombectomy in stroke patients undergoing cardiological procedures. 📷 Join us: DM or contact

📢#ASPERA study has been officialy presented at #ISA-stroke congress 2025 by Matteo Foschi … ➡️DM us Matteo Foschi Raffaele Ornello Simona Sacco Federico De Santis to join the study Università degli Studi dell'Aquila ISAYoung

Simona Sacco Cephalalgia Congrats Simona!!

SISC-IHS guideline for pharmacological treatment of #migraine is now published Cephalalgia Simona Sacco @Schwedtt Messoud Ashina Sait Ashina Jr Wei Wu, MD @Faradoost @ninariggins doi.org/10.1177/033310…

Pleased to share the release of the new Migraine Guideline! A joint effort by the SISC Cefalee and International Headache Society Two versions are available on Cephalalgia : • Summary version: doi.org/10.1177/033310… • Extended version: doi.org/10.1177/033310…

📢 Cephalalgia Fast-Track Review – Accelerate Your Publication Timeline Cephalalgia is pleased to offer a Fast-Track Review option for authors who require a more rapid editorial process. ✅ Editorial review within 72 hours by two experienced Reviewers ✅ Online publication

Mal di testa? Si comincia da piccoli: UnivAQ e SISC tra i banchi per la prevenzione uan.univaq.it/2025/05/19/mal… via @uan.univaq.it

🚀 #ESOC2025 kicked off strong with the ESO EAST Workshop, honoring Robert Mikulik & Veronika Svobodova for their achievments. Welcome to new Chairs Cristina Tiu 🇷🇴 & Adam Kobayashi 🇵🇱! #ESOEAST represents 250M+ Europeans since 2015—driving better stroke care together. 💙

It’s a double life - Stroke was my first love, headache my unexpected path—both have shaped who I am. Thank you The Lancet Neurology for telling my story. 🧠❤️ Simona Sacco: advancing knowledge in stroke and headache - The Lancet Neurology thelancet.com/callback?red_u…

🎉 Congratulations to Federico De Santis, neurologist and PhD candidate at Università degli Studi dell'Aquila, for receiving the European Stroke Org Young Investigator Award! 👏🏻👏🏻👏🏻 A well-deserved recognition! Kudos to Raffaele Ornello, Matteo Foschi and Eleonora De Matteis, key members of the project team. So proud! 💪🏻🧠

Please to share our RCT just published in Cephalalgia. One step forward to advance migraine care

🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin

🚀 Join the Cephalalgia Reviewer Academy 2025/2026! 🚀 Are you a passionate professional about headaches? Boost your CV, gain peer review skills, and connect with experts! Who can apply? - Researchers and healthcare providers interested in headache. - No prior peer review

🧪 New biomarker insights in migraine! A cross-sectional study of over 750 adults reveals: 🔹 Serum GFAP levels are modestly but significantly higher (+6.8%) in people with migraine vs. healthy controls. 🔹 Serum NfL levels? No difference found. 🔹 Results were independent of